Concurrently, assessing the ubiquitination levels of ACSL4 in prostate cancer cells, we ascertained that SKP2’s overexpression markedly amplified ACSL4 ubiquitination in a dose-correlated manner (Fig. 4H). This evidence concerns the gene ACSL4 and Familial prostate cancer.